Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 9 Other hematologic neoplasm 8 Lymphoid 7 Myeloid 5 Classical hematology 2 CNS 2 Sarcoma 1 Other neoplasm 1 Gastrointestinal 1 Dermatologic 1

Conditions

Rectal Neoplasms 1 Colorectal Neoplasms 1

Interventions

Fluorouracil 56 Specimen Handling 51 Oxaliplatin 49 Leucovorin 46 Magnetic Resonance Spectroscopy 45 Bevacizumab 43 Gemcitabine 39 Irinotecan 30 Cetuximab 27 Nivolumab 25 130-nm albumin-bound paclitaxel 25 Cisplatin 24 Biopsy 24 pembrolizumab 22 Paclitaxel 22 Capecitabine 19 atezolizumab 18 durvalumab 14 Taxes 14 Folfox protocol 14 Carboplatin 13 X-Rays 12 Radiotherapy 12 Cyclophosphamide 12 fludarabine 11 dehydroftorafur 10 Radiation 10 Albumin-Bound Paclitaxel 10 Surgical Procedures, Operative 9 Immunoglobulin G 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Melphalan × Gastrointestinal × 30 days × Clear all

NCT06607458 2026-06-01

DEL-LIVER

Delcath Systems Inc.

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡